Medicare GLP-1 Coverage in Delaware (2026)
Browse GLP-1 clinics in Delaware that accept Medicare. Compare providers, check medication availability, and book a consultation.
Reviewed by GlobalGLP1 Editorial Team • Updated May 2026 • Sources: publicly available Medicare coverage data + verified clinic listings
Of the 38 GLP-1 clinics tracked in Delaware, 8 accept Medicare, most concentrated in Dover (4), Middletown (1), Georgetown (1), all offer telehealth, averaging 4.7 stars. Insurance acceptance can change without notice, so confirm coverage with the clinic before your visit.
Cities With Medicare GLP-1 Clinics
GLP-1 Clinics Accepting Medicare in Delaware
Sponsored listings may appear first in default sorting. Ratings, reviews, and medication data are not affected by paid placement. How rankings work
NutriHealth Weight Loss
NutriHealth Weight Loss
NutriHealth Weight Loss
NutriHealth Weight Loss
NutriHealth Weight Loss
It Is Well Healthcare and Medispa
NuvaHealth
Medicare GLP-1 Coverage Details
Coverage Overview
Starting July 1, 2026, Medicare is covering Wegovy and Zepbound for weight loss for the first time, through a program called the Medicare GLP-1 Bridge. The copay is $50 per month, flat, for eligible Part D enrollees. This runs through December 31, 2027. Ozempic and Mounjaro remain covered under standard Part D for type 2 diabetes, as they have been.
Medication Coverage
| Medication | Status | Notes |
|---|---|---|
| Ozempic (semaglutide) | Covered | Covered for type 2 diabetes under Medicare Part D. Not covered for weight loss under the bridge program. If you want semaglutide for weight loss, ask for Wegovy. |
| Wegovy (semaglutide) | Covered | Covered for weight loss starting July 1, 2026 via the Medicare GLP-1 Bridge at a flat $50/month copay. Requires prior authorization and BMI eligibility. Copay does not count toward your Part D deductible or annual out-of-pocket cap. |
| Mounjaro (tirzepatide) | Covered | Covered for type 2 diabetes under standard Part D. Not covered for weight loss under the bridge program. For weight-management tirzepatide coverage, ask for Zepbound. |
| Zepbound (tirzepatide) | Covered | Covered for weight loss starting July 1, 2026 via the Medicare GLP-1 Bridge (KwikPen formulation) at a flat $50/month copay. Same eligibility rules and copay structure as Wegovy under the bridge. |
Cost Estimates
Savings tip: The GLP-1 Bridge $50 copay does not count toward your Part D deductible or the $2,100 annual out-of-pocket cap, and it is not reduced by the Extra Help (Low Income Subsidy). For diabetes GLP-1s (Ozempic, Mounjaro) on standard Part D, the $2,100 annual cap does apply. Manufacturer savings cards cannot be used with any Medicare coverage.
Medicare GLP-1 FAQ for Delaware
There are 8 GLP-1 clinics in Delaware that have reported accepting Medicare insurance. Out of 38 total clinics in the state, these providers can help you access GLP-1 medications with your Medicare plan.
Medicare generally covers GLP-1 medications like Ozempic and Mounjaro for type 2 diabetes across all states including Delaware. Coverage for weight management medications (Wegovy, Zepbound) varies by plan. Contact Medicare directly or check your plan documents for specific coverage details.
Your prescribing doctor in Delaware submits a prior authorization request to Medicare with your diagnosis, BMI, and treatment history. Processing typically takes 2-10 business days. Ask your clinic to submit the request proactively to avoid delays.
You have the right to appeal any denial. Ask your doctor to submit a peer-to-peer review or formal appeal with additional clinical documentation. Many initial denials are overturned on appeal. Delaware insurance regulations may provide additional appeal protections.